Involvement of DT-diaphorase (EC 1.6.99.2) in the DNA cross-linking and sequence selectivity of the bioreductive anti-tumour agent EO9
about
Pharmacological approach towards the development of indolequinone bioreductive drugs based on the clinically inactive agent EO9.Tumor-activated prodrugs--a new approach to cancer therapy.Hypoxia-activated prodrugs in cancer therapy: progress to the clinic.Efficacy, pharmacokinetic and pharmacodynamic evaluation of apaziquone in the treatment of non-muscle invasive bladder cancer.Cobalt complexes with tripodal ligands: implications for the design of drug chaperones.Conformational dynamics is key to understanding loss-of-function of NQO1 cancer-associated polymorphisms and its correction by pharmacological ligands.
P2860
Involvement of DT-diaphorase (EC 1.6.99.2) in the DNA cross-linking and sequence selectivity of the bioreductive anti-tumour agent EO9
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Involvement of DT-diaphorase ( ...... eductive anti-tumour agent EO9
@ast
Involvement of DT-diaphorase ( ...... eductive anti-tumour agent EO9
@en
type
label
Involvement of DT-diaphorase ( ...... eductive anti-tumour agent EO9
@ast
Involvement of DT-diaphorase ( ...... eductive anti-tumour agent EO9
@en
prefLabel
Involvement of DT-diaphorase ( ...... eductive anti-tumour agent EO9
@ast
Involvement of DT-diaphorase ( ...... eductive anti-tumour agent EO9
@en
P2093
P2860
P356
P1476
Involvement of DT-diaphorase ( ...... eductive anti-tumour agent EO9
@en
P2093
Friedlos F
Hartley JA
P2860
P2888
P304
P356
10.1038/BJC.1997.603
P407
P577
1997-01-01T00:00:00Z
P5875
P6179
1031344415